Home » Topics » BioWorld Science

BioWorld Science
RSS

Unifying rare diseases may enable multiple treatments

May 9, 2019

Enrollment completed in second stage of phase II study of bemcentinib plus Keytruda in NSCLC

May 9, 2019

Merck & Co. patents IDO1 inhibitors

May 9, 2019

FDA allows IND application for phase I study of CB-03-10

May 9, 2019

Genetic knockout mice may be an improved model of neuropathic bladder

May 9, 2019

Phase I results presented for LY-3154207

May 9, 2019

Neuropore initiates phase I study of NPT-520-34

May 9, 2019

First clinical data of an ARSB gene therapy for mucopolysaccharidosis type VI

May 9, 2019

NEOLEV2 trial highlights the difficulty of treating neonatal seizures

May 9, 2019

SEECASE trial finds efficacy of NOV-03 in treating dry eye disease

May 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...